Bioequivalence and Bioavailability Forum

Reference Scale Average Bioequivalence Approach- ANVISA, Brazil - Maitri, 2018-09-21 19:49
- RSABE - ANVISA - d_labes, 2018-09-22 14:11

Sample size determination for in-vitro superiority study - sudy, 2018-09-21 08:46

Usage of different lots of RLDs in multistage adaptive studies - manusyriac, 2018-09-20 09:45
- Usage of different lots of RLDs in multistage adaptive studies - ElMaestro, 2018-09-20 12:19
  - Usage of different lots of RLDs in multistage adaptive studies - manusyriac, 2018-09-20 13:05

Endogenous NTI drugs - NK, 2018-09-19 07:31

FDA Supac guidance for ER - jag009, 2018-09-07 20:31
- FDA Supac guidance for ER - Helmut, 2018-09-09 14:04
  - FDA Supac guidance for ER - jag009, 2018-09-10 18:38

EMA Q&A vs EMA Product Specific guideline - Averroes, 2017-10-04 12:01
- Crushed Rivaroxaban? - Averroes, 2018-01-09 12:00
  - Crushed Rivaroxaban? - lukamar, 2018-08-20 12:24

> 5% of Cmax for endogenous molecule? - Ramesh Ramalingam, 2018-06-18 08:00
- Any own thoughts? - Helmut, 2018-06-18 10:59
  - carryover effect in endogenous substances - Ramesh Ramalingam, 2018-08-08 07:29

BE criteria - rajasekharkakarla, 2018-08-03 09:21
- BE criteria - jag009, 2018-08-06 20:35

Bioanalysis discontinued subject - Johanne, 2018-08-02 00:31
- Bioanalysis discontinued subject - Helmut, 2018-08-02 02:02
- Bioanalysis discontinued subject - ElMaestro, 2018-08-02 11:14

Reference trademark issue - rajasekharkakarla, 2018-07-24 09:05
- Note to File - Helmut, 2018-07-24 16:57
  - Note to File - rajasekharkakarla, 2018-07-30 13:37

Not using Biostrength for BE - zheng791, 2018-07-13 21:31
- Not using Biostrength for BE - ElMaestro, 2018-07-13 22:29
- Not using Biostrength for BE - jag009, 2018-07-17 06:32
- Not using Biostrength for BE - sameep, 2018-07-17 06:46

95% UB criteria for FDA - sudy, 2018-07-11 12:31
- No rounding - Helmut, 2018-07-11 14:31

BE study designs for ANVISA - ElMag, 2011-05-11 09:11
- BE study designs for ANVISA - Helmut, 2011-05-11 13:56
  - BE study designs for ANVISA - Mahesh M, 2018-07-11 09:11
    - History… - Helmut, 2018-07-11 11:29

BE tables for topical (dental paste)? - jayashree iyengar, 2018-07-05 21:29

Topical Drugs- IVRT - MaggieSantos, 2018-07-03 18:41

Bio batch for Phase 1 - Kim Christoper, 2018-06-29 10:42

New entry Activity

Bioequivalence and Bioavailability Forum | Admin contact
18,697 posts in 3,982 threads, 1,237 registered users;
online 10 (0 registered, 10 guests [including 8 identified bots]).

Science should always be the basis
of regulatory requirements. Joachim Röhmel

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by

Ing. Helmut Schütz